Cliff Asness's PGEN Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 184,994 shares of Precigen, Inc. (PGEN) worth $715,928, representing 0.00% of the portfolio. First purchased in 2021-Q1, this long-term strategic position has been held for 21 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in PGEN, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2022, adding 219,599 shares. Largest reduction occurred in Q2 2023, reducing 212,629 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Precigen (PGEN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Precigen (PGEN) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -1,406 | Reduce 0.75% | 184,994 | $3.87 |
| Q4 2025 | +79,939 | Add 75.09% | 186,400 | $4.18 |
| Q3 2025 | -11,205 | Reduce 9.52% | 106,461 | $3.29 |
| Q2 2025 | +54,487 | Add 86.24% | 117,666 | $1.42 |
| Q1 2025 | +43,245 | Add 216.94% | 63,179 | $1.49 |
| Q4 2024 | +4,041 | Add 25.43% | 19,934 | $1.12 |
| Q3 2024 | -34,109 | Reduce 68.22% | 15,893 | $0.95 |
| Q2 2024 | +18,097 | Add 56.72% | 50,002 | $1.58 |
| Q1 2024 | +31,905 | New Buy | 31,905 | $1.45 |
| Q4 2023 | -86,614 | Sold Out | 0 | $0.00 |
| Q3 2023 | -56,222 | Reduce 39.36% | 86,614 | $1.42 |
| Q2 2023 | -212,629 | Reduce 59.82% | 142,836 | $1.15 |
| Q1 2023 | -191,431 | Reduce 35.00% | 355,465 | $1.06 |
| Q4 2022 | -72,490 | Reduce 11.70% | 546,896 | $1.52 |
| Q3 2022 | +130,585 | Add 26.72% | 619,386 | $2.12 |
| Q2 2022 | +219,599 | Add 81.57% | 488,801 | $1.34 |
| Q1 2022 | +52,028 | Add 23.96% | 269,202 | $2.11 |
| Q4 2021 | +143,992 | Add 196.76% | 217,174 | $3.71 |
| Q3 2021 | +22,021 | Add 43.04% | 73,182 | $4.99 |
| Q2 2021 | -35,213 | Reduce 40.77% | 51,161 | $6.53 |
| Q1 2021 | +86,374 | New Buy | 86,374 | $6.89 |
Cliff Asness's Precigen Investment FAQs
Cliff Asness first purchased Precigen, Inc. (PGEN) in Q1 2021, acquiring 86,374 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Precigen, Inc. (PGEN) for 21 quarters since Q1 2021.
Cliff Asness's largest addition to Precigen, Inc. (PGEN) was in Q2 2022, adding 488,801 shares worth $655,000.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 184,994 shares of Precigen, Inc. (PGEN), valued at approximately $715,928.
As of the Q1 2026 filing, Precigen, Inc. (PGEN) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Precigen, Inc. (PGEN) was 619,386 shares, as reported at the end of Q3 2022.